Financial ties between authors of the clinical practice guidelines and pharmaceutical companies: an example from Japan

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical microbiology and infection 2019-11, Vol.25 (11), p.1304-1306
Hauptverfasser:	Saito, H., Tani, Y., Ozaki, A., Sawano, T., Shimada, Y., Yamamoto, K., Tanimoto, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - economics Anti-Bacterial Agents - therapeutic use Authorship Clinical practice guidelines Conflict of Interest - economics Disclosure - ethics Drug Industry - economics Drug Industry - ethics Financial conflicts of interest Financial Support - ethics Humans Japan Methicillin-Resistant Staphylococcus aureus - drug effects Methicillin-resistant Staphylococcus aureus guidelines Payments database Practice Guidelines as Topic Practice Patterns, Physicians' - economics Practice Patterns, Physicians' - ethics Staphylococcal Infections - drug therapy Transparency
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!